KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 3 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,010 | -25.1% | 1,500,000 | 0.0% | 0.03% | -22.9% |
Q2 2023 | $2,685 | -54.0% | 1,500,000 | 0.0% | 0.04% | -56.2% |
Q1 2023 | $5,835 | +14.4% | 1,500,000 | 0.0% | 0.08% | +17.6% |
Q4 2022 | $5,100 | -99.9% | 1,500,000 | 0.0% | 0.07% | -39.8% |
Q3 2022 | $8,190,000 | +21.1% | 1,500,000 | 0.0% | 0.11% | +32.9% |
Q2 2022 | $6,765,000 | -38.8% | 1,500,000 | 0.0% | 0.08% | -29.2% |
Q1 2022 | $11,055,000 | +14.6% | 1,500,000 | 0.0% | 0.12% | +31.9% |
Q4 2021 | $9,645,000 | +38.1% | 1,500,000 | +25.0% | 0.09% | +26.4% |
Q3 2021 | $6,984,000 | -43.6% | 1,200,000 | 0.0% | 0.07% | -43.8% |
Q2 2021 | $12,384,000 | -1.9% | 1,200,000 | 0.0% | 0.13% | +3.2% |
Q1 2021 | $12,624,000 | +35.9% | 1,200,000 | +100.0% | 0.12% | +33.3% |
Q4 2020 | $9,288,000 | +2886.5% | 600,000 | +3187.9% | 0.09% | +2225.0% |
Q3 2018 | $311,000 | +17.4% | 18,249 | +16.9% | 0.00% | 0.0% |
Q2 2018 | $265,000 | +26.2% | 15,612 | 0.0% | 0.00% | +33.3% |
Q1 2018 | $210,000 | +36.4% | 15,612 | -2.7% | 0.00% | +50.0% |
Q4 2017 | $154,000 | -24.1% | 16,048 | -13.3% | 0.00% | -33.3% |
Q3 2017 | $203,000 | +43.0% | 18,515 | +18.1% | 0.00% | +50.0% |
Q2 2017 | $142,000 | -34.6% | 15,678 | -7.4% | 0.00% | -50.0% |
Q1 2017 | $217,000 | +77.9% | 16,928 | +30.2% | 0.00% | +100.0% |
Q4 2016 | $122,000 | – | 13,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |